Edaravone, a potent free radical scavenger, reacts with peroxynitrite to produce predominantly 4-NO-edaravone

Redox Report

Volumn 21, Issue 3, 2016, Pages 98-103

  Fujisawa, Akio ^a   Yamamoto, Yorihiro ^a  

^a TOKYO UNIVERSITY OF TECHNOLOGY   (Japan)

Author keywords

4 NO edaravone; 4 NO2 edaravone; Edaravone; Peroxynitrite; Uric acid

Indexed keywords

2 OXO 3 (PHENYLHYDRAZONO)BUTANOIC ACID; 3 NITROTYROSINE; 4 NITRIC OXIDE EDARAVONE; 4 OXOEDARAVONE; BUTYRIC ACID; NORPHENAZONE; PEROXY RADICAL; PEROXYNITRITE; UNCLASSIFIED DRUG; URIC ACID; NEUROPROTECTIVE AGENT; PEROXYNITROUS ACID; PHENAZONE; PHENYLMETHYLPYRAZOLONE; SCAVENGER;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CEREBROSPINAL FLUID; CHEMICAL REACTION; DRUG POTENCY; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; CHEMISTRY; LIPID PEROXIDATION; OXIDATION REDUCTION REACTION;

ANTIPYRINE; FREE RADICAL SCAVENGERS; LIPID PEROXIDATION; NEUROPROTECTIVE AGENTS; OXIDATION-REDUCTION; PEROXYNITROUS ACID; URIC ACID;

EID: 84978726307     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/1351000215Y.0000000025     Document Type: Article

References (30)

1. J.W.Schmidley. Free radicals in central nervous system ischemia. Stroke 1990;21:1086–90. doi: 10.1161/01.STR.21.7.1086
2. B.Halliwell. Reactive oxygen species and the central nervous system. J Neurochem 1992;59:1609–23. doi: 10.1111/j.1471-4159.1992.tb10990.x
3. Y.Yamamoto, T.Kuwahara, K.Watanabe, K.Watanabe. Antioxidant activity of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186). Redox Rep 1996;2:333–8.
4. Edaravone Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction: randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis 2003;15:222–9. doi: 10.1159/000069318
5. K.Watanabe, K.Watanabe, T.Kuwahara, Y.Yamamoto. Free radical-induced oxidation products of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186). J Jpn Oil Chem Soc 1997;46:797–801. doi: 10.5650/jos1996.46.797
6. K.Abe, S.Yuki, K.Kogure. Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 1988;19:480–5. doi: 10.1161/01.STR.19.4.480
7. H.Shichinohe, S.Kuroda, H.Yasuda, T.Ishikawa, M.Iwai, M.Horiuchi, Neuroprotective effects of the free radical scavenger edaravone (MCI-186) in mice permanent focal brain ischemia. Brain Res 2004;1029:200–6. doi: 10.1016/j.brainres.2004.09.055
8. N.Zhang, M.Komine-Kobayashi, R.Tanaka, M.Liu, Y.Mizuno, T.Urabe. Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain. Stroke 2005;36:2220–5. doi: 10.1161/01.STR.0000182241.07096.06
9. H.Kawai, H.Nakai, M.Suga, S.Yuki, T.Watanabe, K.Saito. Effects of a novel free radical scavenger, MCl-186, on ischemic brain damage in the rat distal middle cerebral artery occlusion model. J Pharmacol Exp Ther 1997;281:921–7.
10. Y.Yamamoto, M.Yanagisawa, N.W.Tak, K.Watanabe, C.Takahashi, A.Fujisawa, Repeated edaravone treatment reduces oxidative cell damage in rat brain induced by middle cerebral artery occlusion. Redox Rep 2009;14:251–8. doi: 10.1179/135100009X12525712409779
11. S.Love. Oxidative stress in brain ischemia. Brain Pathol 1999;9:119–31. doi: 10.1111/j.1750-3639.1999.tb00214.x
12. G.Szabó, S.Loganathan, B.Merkely, J.T.Groves, M.Karck, C.Szabó, Catalytic peroxynitrite decomposition improves reperfusion injury after heart transplantation. J Thorac Cardiovasc Surg 2012;143:1443–9. doi: 10.1016/j.jtcvs.2012.02.008
13. Y.Suofu, J.Clark, J.Broderick, K.R.Wagner, T.Tomsick, Y.Sa, Peroxynitrite decomposition catalyst prevents matrix metalloproteinase activation and neurovascular injury after prolonged cerebral ischemia in rats. J Neurochem 2010;115:1266–76. doi: 10.1111/j.1471-4159.2010.07026.x
14. L.Zhang, C.L.Chen, P.T.Kang, V.Garg, K.Hu, K.B.Green-Church, Peroxynitrite-mediated oxidative modifications of complex II: relevance in myocardial infarction. Biochemistry 2010;49:2529–39. doi: 10.1021/bi9018237
15. L.M.Walker, P.D.Walker, S.Z.Imam, S.F.Ali, P.R.Mayeux. Evidence for peroxynitrite formation in renal ischemia–reperfusion injury: studies with the inducible nitric oxide synthase inhibitor l-N(6)-(1-iminoethyl)lysine. J Pharmacol Exp Ther 2000;295:417–22.
16. A.Guven, B.Uysal, O.Akgul, H.Cermik, G.Gundogdu, I.Surer, Scavenging of peroxynitrite reduces renal ischemia/reperfusion injury. Ren Fail 2008;30:747–54. doi: 10.1080/08860220802213039
17. T.Nauser, Koppenol WH. The rate constant of the reaction of superoxide with nitrogen monoxide: approaching the diffusion limit. J Phys Chem A 2002;106:4084–6. doi: 10.1021/jp025518z
18. P.Pacher, J.S.Beckman, L.Liaudet. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007;87:315–424. doi: 10.1152/physrev.00029.2006
19. M.Banno, T.Mizuno, H.Kato, G.Zhang, J.Kawanokuchi, J.Wang, The radical scavenger edaravone prevents oxidative neurotoxicity induced by peroxynitrite and activated microglia. Neuropharmacology 2005;48:283–90. doi: 10.1016/j.neuropharm.2004.10.002
20. P.Dohare, M.C.Hyzinski-García, A.Vipani, N.H.Bowens, J.W.Nalwalk, P.J.Feustel, The neuroprotective properties of the superoxide dismutase mimetic tempol correlate with its ability to reduce pathological glutamate release in a rodent model of stroke. Free Radic Biol Med 2014;77:168–82. doi: 10.1016/j.freeradbiomed.2014.08.029
21. C.X.Santos, E.I.Anjos, O.Augusto. Uric acid oxidation by peroxynitrite: multiple reactions, free radical formation, and amplification of lipid oxidation. Arch Biochem Biophys 1999;37:285–94. doi: 10.1006/abbi.1999.1491
22. K.Tsukada, T.Hasegawa, S.Tsutsumi, H.Katoh, H.Kuwano, T.Miyazaki, Effect of uric acid on liver injury during hemorrhagic shock. Surgery 2000;127:439–46. doi: 10.1067/msy.2000.104486
23. G.S.Scott, S.Cuzzocrea, T.Genovese, H.Koprowski, D.C.Hooper. Uric acid protects against secondary damage after spinal cord injury. Proc Natl Acad Sci U S A 2005;102:3483–8. doi: 10.1073/pnas.0500307102
24. Y.Kato, S.Kawakishi, T.Aoki, K.Itakura, T.Osawa. Oxidative modification of tryptophan residues exposed to peroxynitrite. Biochem Biophys Res Commun 1997;234:82–4. doi: 10.1006/bbrc.1997.6587
25. R.Radi. Peroxynitrite, a stealthy biological oxidant. J Biol Chem 2013;288:26464–72. doi: 10.1074/jbc.R113.472936
26. S.Carballal, S.Bartesaghi, R.Radi. Kinetic and mechanistic considerations to assess the biological fate of peroxynitrite. Biochim Biophys Acta 2014;1840:768–80. doi: 10.1016/j.bbagen.2013.07.005
27. M.K.Kutzing, B.L.Firestein. Altered uric acid levels and disease states. J Pharmacol Exp Ther 2008;324:1–7. doi: 10.1124/jpet.107.129031
28. D.Keizman, M.Ish-Shalom, S.Berliner, N.Maimon, Y.Vered, I.Artamonov, Low uric acid levels in serum of patients with ALS: further evidence for oxidative stress? J Neurol Sci 2009;285:95–9. doi: 10.1016/j.jns.2009.06.002
29. H.Yoshino, A.Kimura. Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study). Amyotroph Lateral Scler 2006;7:241–5. doi: 10.1080/17482960600881870
30. M.Nagase, Y.Yamamoto, Y.Miyazaki, H.Yoshino. Increased oxidative stress in patients with amyotrophic lateral sclerosis and the effect of edaravone administration. Redox Rep, 2015;[Epub ahead of print].